What is Pain O Soma 500 Mg ( Carisoprodol )
Pain-O-Soma 500 MG (Carisoprodol 500 Mg tablets), USP is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol tablets, USP should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration.
Pain O Soma is used together with rest and physical therapy to treat skeletal muscle conditions such as pain or injury.
Soma should only be used for short periods (up to two or three weeks) because there is no evidence of its effectiveness in long term use and most skeletal muscle injuries are generally of short duration.
This medication used to prevent pain sensations such as muscle tremor, the stiffness of muscle, and spasm that arises inside the body. Pain O Soma is meant to be used for crushing severe muscle pain. It works on central nervous system and treats moderate to severe muscle related pain.
The most common side effects of carisoprodol are:
- Inability to sleep
- Abnormal heart beat
Serious side effects of carisoprodol include:
- Hives (angioedema)
- Serious allergic reactions (anaphylaxis)
- Low blood pressure
Carisoprodol is not a controlled substance. Patients may become dependent on carisoprodol, and discontinuation after long-term use may cause withdrawal symptoms.
Before taking carisoprodol, tell your doctor or pharmacist if you are allergic to it; or to meprobamate, tybamate, or mebutamate; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: a certain blood disorder (acute intermittent porphyria), kidney disease, liver disease, seizure, personal or family history of a substance use disorder (such as overuse of or addiction to drugs/alcohol).
This drug may make you dizzy or drowsy. Do not drive, use machinery, or do any activity that requires alertness until you are sure you can perform such activities safely. Avoid alcoholic beverages.
Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products).
Older adults may be more sensitive to the side effects of this drug, especially drowsiness, or confusion. These side effects can increase the risk of falling.
This medication is not recommended for use during the first 3 months of pregnancy. It may harm an unborn baby. During the last 6 months of pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.
The sedative effects of SOMA and other CNS depressants (e.g., alcohol, benzodiazepines, opioids, tricyclic antidepressants) may be additive. Therefore, caution should be exercised with patients who take more than one of these CNS depressants simultaneously. Concomitant use of SOMA and meprobamate, a metabolite of SOMA, is not recommended.
Carisoprodol is metabolized in the liver by CYP2C19 to form meprobamate. Co-administration of CYP2C19 inhibitors, such as omeprazole or fluvoxamine, with SOMA could result in increased exposure of carisoprodol and decreased exposure of meprobamate. Co-administration of CYP2C19 inducers, such as rifampin or St. John’s Wort, with SOMA could result in decreased exposure of carisoprodol and increased exposure of meprobamate. Low dose aspirin also showed an induction effect on CYP2C19. The full pharmacological impact of these potential alterations of exposures in terms of either efficacy or safety of SOMA is unknown.